Q1 2024 13F Holders as of 3/31/2024
-
Type / Class
-
Equity / Ordinary Shares, par value 0.00001 NIS per share
-
Shares outstanding
-
240M
-
Number of holders
-
139
-
Total shares
-
75.9M
-
Shares change
-
+10.4M
-
Total reported value, excl. options
-
$836M
-
Value change
-
+$118M
-
Put/Call ratio
-
0.15
-
Number of buys
-
90
-
Number of sells
-
-44
-
Price
-
$11.08
Significant Holders of Cellebrite DI Ltd. - Ordinary Shares, par value 0.00001 NIS per share (CLBT) as of Q1 2024
143 filings reported holding CLBT - Cellebrite DI Ltd. - Ordinary Shares, par value 0.00001 NIS per share as of Q1 2024.
Cellebrite DI Ltd. - Ordinary Shares, par value 0.00001 NIS per share (CLBT) has 139 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 75.9M shares
of 240M outstanding shares and own 31.56% of the company stock.
Largest 10 shareholders include True Wind Capital Management, L.P. (13.4M shares), Clal Insurance Enterprises Holdings Ltd (6.07M shares), MORGAN STANLEY (4.12M shares), CROSSLINK CAPITAL INC (3.6M shares), Nine Ten Capital Management LLC (3.47M shares), Phoenix Holdings Ltd. (3.39M shares), ACADIAN ASSET MANAGEMENT LLC (2.9M shares), Greenhaven Road Investment Management, L.P. (2.64M shares), Voss Capital, LLC (2.3M shares), and ASHFORD CAPITAL MANAGEMENT INC (1.84M shares).
This table shows the top 139 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.